{"id":"tahoe-100m","type":"dataset","name_en":"Tahoe-100M","name_zh":"Tahoe-100M","aliases":[],"description":{"en":"Single-cell perturbation atlas of 100 million cells covering 1,100 drugs across 50 cancer cell lines (preprint; peer-reviewed in Cell 2026). Not GBM-focused.","zh":"包含 1 亿个细胞的单细胞扰动图谱，涵盖 50 个癌细胞系中的 1,100 种药物（预印本；Cell 2026 正式发表）。并非以 GBM 为重点。"},"externalIds":{},"graphNames":[],"mentions":{"items":["VC0041","VC0042","VC0138"],"topics":["perturbation-gbm-therapy"]},"evidenceRefs":["VC0041","VC0042"],"reviewStatus":"draft","version":"0.1.0","page_url":"https://gliostate.com/entities/tahoe-100m/","page_url_zh":"https://gliostate.com/zh/entities/tahoe-100m/","api_url":"https://gliostate.com/api/entities/tahoe-100m.json","external_links":[],"source_file":"https://gliostate.com/data/entities/tahoe-100m.json","evidence_items":[{"id":"VC0041","title":"Tahoe-100M : A Giga-Scale Single-Cell Perturbation Atlas for Context-Dependent Gene Function and Cellular Modeling","year":"2025","page_url":"https://gliostate.com/library/VC0041/","api_url":"https://gliostate.com/api/items/VC0041.json"},{"id":"VC0042","title":"Tahoe-100M: Mapping drug-induced molecular phenotypes at single-cell resolution.","year":"2026","page_url":"https://gliostate.com/library/VC0042/","api_url":"https://gliostate.com/api/items/VC0042.json"}],"mentioned_in_items":[{"id":"VC0041","title":"Tahoe-100M : A Giga-Scale Single-Cell Perturbation Atlas for Context-Dependent Gene Function and Cellular Modeling","year":"2025","page_url":"https://gliostate.com/library/VC0041/","api_url":"https://gliostate.com/api/items/VC0041.json"},{"id":"VC0042","title":"Tahoe-100M: Mapping drug-induced molecular phenotypes at single-cell resolution.","year":"2026","page_url":"https://gliostate.com/library/VC0042/","api_url":"https://gliostate.com/api/items/VC0042.json"},{"id":"VC0138","title":"PerturbLDM: conditional latent diffusion for modelling single-cell perturbation responses","year":"2026","page_url":"https://gliostate.com/library/VC0138/","api_url":"https://gliostate.com/api/items/VC0138.json"}],"mentioned_in_topics":[{"id":"perturbation-gbm-therapy","title_en":"Perturbation data for glioblastoma: radiotherapy, drugs and CRISPR","title_zh":"胶质母细胞瘤扰动数据：放疗、药物与 CRISPR","url":"https://gliostate.com/perturbations/gbm-therapy-perturbations/","api_url":"https://gliostate.com/api/topics/perturbation-gbm-therapy.json"}],"relations":[{"subject":"perturbldm","subject_name_en":"PerturbLDM","subject_name_zh":"PerturbLDM","predicate":"uses_dataset","object":"tahoe-100m","object_name_en":"Tahoe-100M","object_name_zh":"Tahoe-100M","confidence":"high","evidence":[{"id":"VC0138","role":"dataset","title":"PerturbLDM: conditional latent diffusion for modelling single-cell perturbation responses","page_url":"https://gliostate.com/library/VC0138/","api_url":"https://gliostate.com/api/items/VC0138.json"}],"note":{"en":"Preprint: PerturbLDM is pretrained on Tahoe-100M.","zh":"预印本：PerturbLDM 在 Tahoe-100M 上预训练。"},"sources":[{"kind":"entity","id":"perturbldm"}]}],"related_entities":[{"id":"perturbldm","type":"model","name_en":"PerturbLDM","name_zh":"PerturbLDM","page_url":"https://gliostate.com/entities/perturbldm/","page_url_zh":"https://gliostate.com/zh/entities/perturbldm/","api_url":"https://gliostate.com/api/entities/perturbldm.json","via":"relation"},{"id":"crispri","type":"method","name_en":"CRISPR interference (CRISPRi)","name_zh":"CRISPR 干扰（CRISPRi）","page_url":"https://gliostate.com/entities/crispri/","page_url_zh":"https://gliostate.com/zh/entities/crispri/","api_url":"https://gliostate.com/api/entities/crispri.json","via":"co-mention"},{"id":"delphai","type":"model","name_en":"DELPHAI","name_zh":"DELPHAI","page_url":"https://gliostate.com/entities/delphai/","page_url_zh":"https://gliostate.com/zh/entities/delphai/","api_url":"https://gliostate.com/api/entities/delphai.json","via":"co-mention"},{"id":"gbm-organoid","type":"model","name_en":"Patient-derived GBM organoids","name_zh":"患者来源 GBM 类器官","page_url":"https://gliostate.com/entities/gbm-organoid/","page_url_zh":"https://gliostate.com/zh/entities/gbm-organoid/","api_url":"https://gliostate.com/api/entities/gbm-organoid.json","via":"co-mention"},{"id":"glioblastoma","type":"disease","name_en":"Glioblastoma (GBM)","name_zh":"胶质母细胞瘤（GBM）","page_url":"https://gliostate.com/entities/glioblastoma/","page_url_zh":"https://gliostate.com/zh/entities/glioblastoma/","api_url":"https://gliostate.com/api/entities/glioblastoma.json","via":"co-mention"},{"id":"lincs-l1000","type":"dataset","name_en":"LINCS L1000 drug signatures","name_zh":"LINCS L1000 药物特征谱","page_url":"https://gliostate.com/entities/lincs-l1000/","page_url_zh":"https://gliostate.com/zh/entities/lincs-l1000/","api_url":"https://gliostate.com/api/entities/lincs-l1000.json","via":"co-mention"},{"id":"organoid-drug-screen","type":"method","name_en":"Organoid drug screening","name_zh":"类器官药物筛选","page_url":"https://gliostate.com/entities/organoid-drug-screen/","page_url_zh":"https://gliostate.com/zh/entities/organoid-drug-screen/","api_url":"https://gliostate.com/api/entities/organoid-drug-screen.json","via":"co-mention"},{"id":"perturb-seq","type":"method","name_en":"Perturb-seq","name_zh":"Perturb-seq（扰动单细胞测序）","page_url":"https://gliostate.com/entities/perturb-seq/","page_url_zh":"https://gliostate.com/zh/entities/perturb-seq/","api_url":"https://gliostate.com/api/entities/perturb-seq.json","via":"co-mention"}]}